Biotech

All Articles

FDA places Kezar lupus test in hold adhering to 4 individual deaths

.The FDA has put Kezar Lifestyle Sciences' lupus trial on hold after the biotech flagged four fatali...

Phase 3 Historian Rock test attacks SMA target, delivering stockpile 200%

.A stage 3 trial of Intellectual Rock's spinal muscle atrophy (SMA) prospect has actually attacked i...

CAMP 4 is actually most recent to eye IPO, while Upstream point out $182M program

.RNA biotech CAMP4 Therapies has actually defined plans for a $67 million IPO, with inflammation-foc...

Galecto gets leukemia drug, falls bone cancer asset in pivot

.A year after the failure of an idiopathic pulmonary fibrosis prospect delivered Galecto on a hunt f...

Judo tosses down $100M to knock senseless kidney illness

.Taking the floor covering is Judo Bio, an ambitious biotech equipped along with $one hundred millio...

AstraZeneca pays for CSPC $100M for preclinical heart problem medication

.AstraZeneca has actually settled CSPC Pharmaceutical Group $one hundred thousand for a preclinical ...

Zephyrm looks for Hong Kong IPO to fund phase 3 tissue therapy trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO...

Frazier Lifestyle Sciences collects $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has sourced an even more $630 million for its fund focused on tiny and ...

GigaGen gets as much as $135M BARDA dollars to beat botox

.Antitoxin fan GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its own te...

GPCR company Septerna declare IPO on stamina of preclinical data

.Septerna will learn how a biotech without "any purposeful scientific records" meals in the overdue ...